Text Size

Efficacy and safety of a cationic emulsion in the treatment of moderate to severe dry eye disease: A randomized controlled study

Robert P.-Y., Cochener B., Amrane M., Ismail D., Garrigue J.-S., Pisella P.-J., Baudouin C.


  • 2016
  • European Journal of Ophthalmology
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Clinical development

  • Affiliations

    Department of Ophthalmology, Dupuytren University Hospital, Limoges, France; Brest University Medical School, Department of Ophthalmology, Morvan Hospital, Brest, France; Santen SAS, Evry, France; François Rabelais University, Tours, France; Department of Ophthalmology, Bretonneau Hospital, Tours, France; Quinze-Vingts National Ophthalmology Hospital, Paris, France; UPMC University, Paris 6, Vision Institute, INSERM UMRS968, CNRS UMR7210, Paris, France; University of Versailles, Saint-Quentin en Yvelines, Versailles, France

Related Publications

Trans-eyelid distribution of epinastine to the conjunctiva following eyelid application in rabbits

Mochizuki T.; Hata T.; Mori N.; Yamazaki T.; Noto T.; Mano H.


Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis

Koo E.B.; Yu T.M.; Layton A.J.; Babineaux S.; Fung S.


Review of clinical outcomes of a cationic emulsion tear substitute in patients with dry eye disease

Labetoulle M, Garhöfer G, Ismail D, Garrigue JS, Amrane M, Guillon M, Aragona P, Baudouin C.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022